Hong Kong Stock Movement
Stocks Ranked Among the Top in Market Capitalization in the Industry
GuoShengTang fell 0.18%, with a market capitalization of HKD 7.925 billion. Based on recent key news:
<ol>
<li>
On September 9, Haitong International released a research report, maintaining GuoShengTang's &#34;Outperform&#34; rating, with a target price of HKD 67.35. The firm expects GuoShengTang's revenue for 2025 and 2026 to be HKD 3.4 billion and HKD 4.03 billion, respectively, representing year-on-year growth of 12.5% and 18.5%, with net profit attributable to the parent company expected to be HKD 410 million and HKD 490 million, representing year-on-year growth of 32.4% and 19.6%.
</li>
<li>
On September 9, China Merchants International reported that the overall performance of the pharmaceutical industry still requires time to improve, but benefiting from the overseas transactions of innovative drugs and the optimization of domestic centralized procurement policies, the pharmaceutical industry is expected to continue to rise. GuoShengTang is recommended as a buy target, with a target price of HKD 48.28.
</li>
<li>
On September 8, GuoShengTang released its mid-term results for 2025, with revenue increasing by 9.5% year-on-year to HKD 1.49 billion, and net profit increasing by 41.6% year-on-year to HKD 150 million. The company announced a stock repurchase plan of HKD 30 million and launched the &#34;National Medicine AI Avatar&#34; system. The pharmaceutical industry is driven by the overseas expansion of innovative drugs and policy optimization
</li>
</ol>

02587

HEALTHYWAY INC rose by 10.66%; Yimai Sunshine rose by 0.71%, with a transaction volume of HKD 128 million; Jinxin Fertility rose by 0.37%, with a transaction volume of HKD 92.9 million; Global Medical fell by 0.15%, with a transaction volume of HKD 31.75 million; Guoshengtang fell by 0.18%, with a market value of HKD 7.925 billion

Hong Kong Stock Movement: HEALTHYWAY INC rises 10.66%